首页> 外文期刊>Chinese Medicine >Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder
【24h】

Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder

机译:血液和尿液代谢组学证据证实中医对重度抑郁症的诊断分类

获取原文
           

摘要

Major depressive disorder (MDD) is a highly heterogeneous disease. Further classification may characterize its heterogeneity. The purpose of this study was to examine whether metabolomic variables could differentiate traditional Chinese medicine (TCM) diagnostic subtypes of MDD. Fifty medication-free patients who were experiencing a recurrent depressive episode were classified into Liver Qi Stagnation (LQS, n?=?30) and Heart and Spleen Deficiency (HSD, n?=?20) subtypes according to TCM diagnosis. Healthy volunteers (n?=?28) were included as controls. Gas chromatography-mass spectrometry (GC–MS) was used to examine serum and urinary metabolomic profiles. Twenty-eight metabolites were identified for good separations between TCM subtypes and healthy controls in serum samples. Both TCM subtypes had similar profiles in proteinogenic branched-chain amino acids (BCAAs) (valine, leucine, and isoleucine) and energy metabolism-related metabolites that were differentiated from healthy controls. The LQS subtype additionally differed from healthy controls in multiple amino acid metabolites that are involved in biosynthesis of monoamine and amino acid neurotransmitters, including phenylalanine, 3-hydroxybutric acid, o-tyrosine, glycine, l-tryptophan, and N-acetyl-l-aspartic acid. Threonic acid, methionine, stearic acid, and isobutyric acid are differentially associated with the two subtypes. While both TCM subtypes are associated with aberrant BCAA and energy metabolism, the LQS subtype may represent an MDD subpopulation characterized by abnormalities in the biosynthesis of monoamine and amino acid neurotransmitters and closer associations with stress-related pathophysiology. The metabolites differentially associated with the two subtypes are promising biomarkers for predicting TCM subtype-specific antidepressant response [registered at http://www.clinicaltrials.gov (NCT02346682) on January 27, 2015].
机译:严重抑郁症(MDD)是一种高度异质的疾病。进一步分类可以表征其异质性。这项研究的目的是检查代谢组学变量是否可以区分MDD的中医诊断亚型。根据中医诊断,将50例复发性抑郁发作的无药患者分为肝气郁结(LQS,n≥30)和心脾脾虚(HSD,n≥20)亚型。纳入健康志愿者(n = 28)作为对照。气相色谱-质谱(GC-MS)用于检查血清和尿代谢组学特征。鉴定出二十八种代谢物,可在血清样品中的中医亚型和健康对照之间实现良好分离。两种中医亚型在与健康对照组不同的蛋白原性支链氨基酸(BCAA)(缬氨酸,亮氨酸和异亮氨酸)和能量代谢相关的代谢产物中具有相似的特征。 LQS亚型还不同于健康对照,其涉及多种氨基酸代谢物,这些代谢物涉及单胺和氨基酸神经递质的生物合成,包括苯丙氨酸,3-羟基丁酸,邻酪氨酸,甘氨酸,左色氨酸和N-乙酰基-1-天冬氨酸。苏糖酸,蛋氨酸,硬脂酸和异丁酸与这两种亚型不同。虽然这两种中医亚型都与异常的BCAA和能量代谢有关,但LQS亚型可能代表MDD亚群,其特征在于单胺和氨基酸神经递质的生物合成异常以及与压力相关的病理生理学的密切联系。与这两种亚型差异相关的代谢产物有望用于预测TCM亚型特异性抗抑郁药反应[2015年1月27日在http://www.clinicaltrials.gov(NCT02346682)注册]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号